Gujarat Alkalies Recommends Final Dividend of ₹17.70/Share; Q4 Results Filed
Gujarat Alkalies recommended a final dividend of ₹17.70 per share. The company reported Q4 FY26 results with total income from operations at ₹11,2531 lakhs and net profit after tax at ₹793 lakhs. For the full year FY26, total income was ₹4,35,808 lakhs and net profit after tax was ₹2,084 lakhs. The Board approved these results on May 29, 2026.
The announcement of financial results and dividend recommendation are material information for investors, impacting investment decisions and stock valuation.
The recommendation of a final dividend and the filing of audited financial results, even with mixed profit figures, are generally viewed positively by the market.
Gujarat Alkalies and Chemicals Limited has announced its audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. The company's Board of Directors has recommended a final dividend of ₹17.70 per equity share of ₹10 each, amounting to ₹12,998.34 lakhs. This recommendation was approved by the Board in meetings held on May 25, 2026, and May 29, 2026.
The financial results were published on May 30, 2026, in the Financial Express newspaper (All India Edition and All Gujarat Edition). The company reported total income from operations of ₹11,2531 lakhs for the fourth quarter ended March 31, 2026, compared to ₹1,07,547 lakhs in the corresponding quarter of the previous year. For the full financial year ended March 31, 2026, the total income from operations stood at ₹4,35,808 lakhs, up from ₹4,07,291 lakhs in the previous financial year.
Net profit after tax for the fourth quarter was ₹793 lakhs, while for the full financial year, it was ₹2,084 lakhs. The company also noted that its operations fall under a single segment, "Chemicals." The announcement also detailed an impairment review of its investment in a Joint Venture, GACL-NALCO Alkalies & Chemicals Private Limited, concluding that no impairment provision is required as the fair value exceeds the carrying value. The consolidated financial results include the outcomes of this joint venture and associates.
What to do with a filing like this
Gujarat Alkalies and Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Alkalies and Chemicals Limited. Read the original for the full detail.